What is the recommended steroid regimen for treating croup in children, including drug choice, dosage, and route?

Steroid Treatment for Croup in Children

For children with croup, administer a single dose of oral dexamethasone 0.6 mg/kg (maximum 10-16 mg) or nebulized budesonide 2 mg as the first-line corticosteroid therapy.

Drug Choice and Route

The evidence strongly supports oral dexamethasone as the preferred steroid for croup management. While the provided guidelines don't explicitly detail the complete steroid regimen for croup, they reference nebulized steroids as an option 1. The British Thoracic Society guidelines note that nebulized budesonide (500 µg) may reduce symptoms in croup within the first two hours, though they acknowledge limited data on longer-term use or ultimate outcomes 1.

More recent evidence from 2022 demonstrates successful implementation of croup management protocols that reduced hospital admissions by 37% (95% CI: 8-66%) 2. This guideline emphasized appropriate use of racemic epinephrine and monitoring protocols, working in conjunction with corticosteroid therapy.

Dosing Regimen

Based on the available evidence:

• Oral dexamethasone: Single dose of 0.6 mg/kg (typical maximum 10-16 mg)
• Nebulized budesonide: 500 µg to 2 mg as alternative route 1
• Oral prednisolone: 2 mg/kg/day for 3 days (maximum 40 mg/day) can be considered, though this is referenced more for asthma management 1

Clinical Algorithm

1. Initial assessment: Evaluate severity of stridor, work of breathing, and respiratory distress
2. First-line therapy: Administer single dose of oral dexamethasone 0.6 mg/kg
3. Nebulized epinephrine: Reserve for moderate-to-severe croup with significant stridor at rest
   • Dose: 0.5 mL/kg of 1:1000 solution (maximum 5 mL) by nebulizer 3
   • Alternative: Racemic epinephrine 0.05 mL/kg of 2.25% solution (maximum 0.5 mL) in 2 mL normal saline 3
4. Observation period: Monitor for 2 hours after second dose of racemic epinephrine before determining need for admission 2

Critical Caveats

Important limitation: Nebulized epinephrine effects are short-lived (1-2 hours) and should not be used in children who will be discharged shortly or on an outpatient basis 1. The 2022 guideline implementation showed that monitoring patients up to 2 hours after their second racemic epinephrine dose, rather than automatically admitting, reduced unnecessary hospitalizations by over 50% among patients receiving ≤2 doses 2.

Steroid considerations: The British Thoracic Society notes that while nebulized steroids may reduce symptoms in the first two hours, there is no data on longer-term use or effect on eventual outcomes 1. A single dose of systemic corticosteroid (oral dexamethasone) remains the evidence-based standard.

Avoid: Do not use repeated doses of corticosteroids beyond the initial single dose, as there is no evidence supporting this practice for croup. The European Respiratory Society guidelines confirm that oral dexamethasone and nebulized corticosteroids are equally effective, but corticosteroids from hand-held inhalers with spacers have not been shown effective 4.